Related Experiment Videos
Seasickness treatment with cinnarizine
Bulletin of the Institute of Maritime and Tropical Medicine in Gdynia
|January 1, 1983
Summary
Cinnarizine effectively treats seasickness in ship passengers. Compared to Aviomarin and placebo, cinnarizine demonstrated superior efficacy, suggesting it as a recommended therapy for motion sickness.
Area of Science:
- Pharmacology
- Clinical Medicine
- Traveler's Health
Background:
- Seasickness, a common form of motion sickness, affects numerous individuals during sea travel.
- Effective pharmacological interventions are crucial for managing seasickness symptoms.
Purpose of the Study:
- To investigate the therapeutic efficacy of cinnarizine in treating seasickness.
- To compare the effectiveness of cinnarizine against Aviomarin and a placebo.
Main Methods:
- A clinical investigation involving 112 ship passengers experiencing seasickness.
- Administration of cinnarizine, Aviomarin, and a placebo to different groups for comparison.
Main Results:
- Cinnarizine showed significant therapeutic effects in the majority of seasickness cases.
- Only 5 cases (4.5%) reported no improvement, and 7 (6.25%) had questionable results.
- Cinnarizine demonstrated superior efficacy compared to both Aviomarin and placebo groups.
Conclusions:
- Cinnarizine is a highly effective medication for treating seasickness.
- The study supports the recommendation of cinnarizine therapy for individuals suffering from motion sickness during sea voyages.